Compounds > sirolimus

sirolimus and Granulomatosis-with-Polyangiitis

sirolimus has been researched along with Granulomatosis-with-Polyangiitis* in 2 studies

Other Studies

2 other study(ies) available for sirolimus and Granulomatosis-with-Polyangiitis

ArticleYear
Sirolimus use in patients with subglottic stenosis in the context of granulomatosis with polyangiitis (GPA), suspected GPA, and immunoglobulin G
    Scandinavian journal of rheumatology, 2021, Volume: 50, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Female; Granulomatosis with Polyangiitis; Humans; Immunoglobulin G4-Related Disease; Laryngostenosis; Male; Retrospective Studies; Sirolimus; Treatment Outcome

2021
Limited utility of rapamycin in severe, refractory Wegener's granulomatosis.
    The Journal of rheumatology, 2009, Volume: 36, Issue:1

    We report our experience using rapamycin in patients with Wegener's granulomatosis (WG) who failed to achieve remission with conventional treatment.. Eight patients received rapamycin for severe, refractory WG. Clinical outcomes were reviewed retrospectively.. Four patients treated with rapamycin sustained remissions of at least 6 months' duration while receiving prednisone

    Topics: Adult; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Sirolimus; Treatment Failure; Young Adult

2009